Drugs Made In America Acquisition II Ord Shs
DMII10.000USD
+0.010+0.10%
收盤 02/09, 16:00（美東）報價延遲15分鐘
512.00M總市值
--本益比TTM
關於 Drugs Made In America Acquisition II Ord Shs 公司
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition II Ord Shs簡介
公司代碼DMII
公司名稱Drugs Made In America Acquisition II Corp
上市日期Sep 25, 2025
CEOStockwell (Lynn)
員工數量- -
證券類型Ordinary Share
年結日- -
公司地址1 East Broward Boulevard
城市FT LAUDERDALE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編33301
電話19548703099
網址
公司代碼DMII
上市日期Sep 25, 2025
CEOStockwell (Lynn)
Drugs Made In America Acquisition II Ord Shs公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
+100000.00%
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
+100000.00%
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
+100000.00%
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
+100000.00%
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
+100000.00%
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
+100000.00%
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
收入明細
由於公司未披露，未能獲取相關數據
由於公司未披露，未能獲取相關數據
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 3 小時前
更新時間: 3 小時前
持股股東
股東類型
持股股東
持股股東
佔比
Drugs Made In America Acquisition II LLC
7.37%
Conaway (Charles C.)
3.05%
MAABS, LLC
2.03%
King (Michael)
2.03%
Wolverine Asset Management, LLC
1.62%
其他
83.89%
持股股東
持股股東
佔比
Drugs Made In America Acquisition II LLC
7.37%
Conaway (Charles C.)
3.05%
MAABS, LLC
2.03%
King (Michael)
2.03%
Wolverine Asset Management, LLC
1.62%
其他
83.89%
股東類型
持股股東
佔比
Corporation
9.40%
Individual Investor
8.23%
Investment Advisor
2.90%
Hedge Fund
1.62%
Investment Advisor/Hedge Fund
0.12%
其他
77.72%
機構持股
更新時間: 1月21日 週三
更新時間: 1月21日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q4
1
666.67K
0.00%
--
2025Q4
7
3.04M
4.64%
+3.04M
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Drugs Made In America Acquisition II LLC
4.83M
7.37%
+4.83M
--
Dec 03, 2025
Conaway (Charles C.)
2.00M
3.05%
+2.00M
--
Dec 03, 2025
MAABS, LLC
1.33M
2.03%
+1.33M
--
Dec 03, 2025
King (Michael)
1.33M
2.03%
+1.33M
--
Dec 03, 2025
Robinson (Edward)
1.00M
1.52%
+1.00M
--
Dec 03, 2025
Jessnick Capital Management, LLC
666.67K
1.02%
+666.67K
--
Dec 03, 2025
Higbee (Tyler)
666.67K
1.02%
+666.67K
--
Dec 03, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
